研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2017 年的期刊文章
共 1233 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2017-12-29 到 2017-12-14。
按期刊看(展开)
- JASA Journal of the American Statistical Association · 169 篇
- AoS Annals of Statistics · 90 篇
- JRSSB Journal of the Royal Statistical Society Series B · 33 篇
- Biometrika Biometrika · 76 篇
- Biometrics Biometrics · 152 篇
- SiM Statistics in Medicine · 329 篇
- SMMR Statistical Methods in Medical Research · 178 篇
- JMLR Journal of Machine Learning Research · 149 篇
- Econometrica Econometrica · 57 篇
按主题看(展开)
Biometrics Survival Analysis Nonparametric & Semiparametric Testing & Uncertainty · 发表于 2017-12-29
Sy Han Chiou, Gongjun Xu, Jun Yan, Chiung-Yu Huang
摘要
Summary: Panel count data arise when the number of recurrent events experienced by each subject is observed intermittently at discrete examination times. The examination time process can be informative about the underlying recurrent event process even after conditioning on covariates. We consider a semiparametric accelerated mean model for the recurrent event process and allow the two processes to be correlated through a shared frailty. The regression parameters have a simple marginal interpretation of modifying the time scale of the cumulative mean function of the event process. A novel estimation procedure for the regression parameters and the baseline rate function is proposed based on a conditioning technique. In contrast to existing methods, the proposed method is robust in the sense that it requires neither the strong Poisson-type assumption for the underlying recurrent event process nor a parametric assumption on the distribution of the unobserved frailty. Moreover, the distribution of the examination time process is left unspecified, allowing for arbitrary dependence between the two processes. Asymptotic consistency of the estimator is established, and the variance of the estimator is estimated by a model-based smoothed bootstrap procedure. Numerical studies demonstrated that the proposed point estimator and variance estimator perform well with practical sample sizes. The methods are applied to data from a skin cancer chemoprevention trial.
Biometrics Nonparametric & Semiparametric · 发表于 2017-12-29
Yinghao Pan, Jianwen Cai, Sangmi Kim, Haibo Zhou
摘要
Summary: Case-cohort study design has been widely used for its cost-effectiveness. In any real study, there are always other important outcomes of interest beside the failure time that the original case-cohort study is based on. How to utilize the available case-cohort data to study the relationship of a secondary outcome with the primary exposure obtained through the case-cohort study is not well studied. In this article, we propose a non-parametric estimated likelihood approach for analyzing a secondary outcome in a case-cohort study. The estimation is based on maximizing a semiparametric likelihood function that is built jointly on both time-to-failure outcome and the secondary outcome. The proposed estimator is shown to be consistent, efficient, and asymptotically normal. Finite sample performance is evaluated via simulation studies. Data from the Sister Study is analyzed to illustrate our method.
SiM Survival Analysis · 发表于 2017-12-28
Andreas Gleiss, Michael Gnant, Michael Schemper
摘要
Explained variation measures the relative gain in predictive accuracy when prediction based on prognostic factors replaces unconditional prediction. The factors may be measured on different scales or may be of different types (dichotomous, qualitative, or continuous). Thus, explained variation permits to establish a ranking of the importance of factors, even if predictive accuracy is too low to be helpful in clinical practice. In this contribution, the explained variation measure by Schemper and Henderson (2000) is extended to accommodate random factors, such as center effects in multicenter studies. This permits a direct comparison of the importance of centers and of other prognostic factors. We develop this extension for a shared frailty Cox model and provide an SAS macro and an R function to facilitate its application. Interesting empirical properties of the variation explained by a random factor are explored by a Monte Carlo study. Advantages of the approach are exemplified by an Austrian multicenter study of colon cancer.
SMMR Causal Inference · 发表于 2017-12-28
Kung-Jong Lui
摘要
To increase power or reduce the number of patients needed in trials studying treatments for psychiatric or mental disorders with a high placebo response rate, we may consider use of the sequential parallel comparison design proposed elsewhere. Because statistical significance does not necessarily imply that the difference between treatment and placebo is of clinical importance, it is always of importance to quantify the treatment effect in clinical trials. When the patient responses are dichotomous, the treatment and other covariates effects are not likely additive. Thus, using a weighted average of the risk differences over two phases may not be a meaningful summary index to measure the treatment effect. To alleviate this concern, we consider use of the relative difference or relative risk reduction to measure the treatment effect. We derive both point and interval estimators for the relative difference by use of the weighted-least-squares estimator and Mantel-Haenszel type estimator. We employ Monte Carlo simulation to evaluate the finite-sample performance of these estimators in a variety of situations. We also include a procedure for testing the homogeneity of the relative difference between phases under the sequential parallel comparison design. We use the placebo-controlled study to assess the efficacy of a low dose of aripiprazole adjunctive to antidepressant therapy in the treatment of patients with major depressive disorder to illustrate the use of estimators developed here.
SMMR Bayesian Methods Survival Analysis Clinical Trials · 发表于 2017-12-28
Anja Bertsche, Frank Fleischer, Jan Beyersmann, Gerhard Nehmiz
摘要
After exploratory drug development, companies face the decision whether to initiate confirmatory trials based on limited efficacy information. This proof-of-concept decision is typically performed after a Phase II trial studying a novel treatment versus either placebo or an active comparator. The article aims to optimize the design of such a proof-of-concept trial with respect to decision making. We incorporate historical information and develop pre-specified decision criteria accounting for the uncertainty of the observed treatment effect. We optimize these criteria based on sensitivity and specificity, given the historical information. Specifically, time-to-event data are considered in a randomized 2-arm trial with additional prior information on the control treatment. The proof-of-concept criterion uses treatment effect size, rather than significance. Criteria are defined on the posterior distribution of the hazard ratio given the Phase II data and the historical control information. Event times are exponentially modeled within groups, allowing for group-specific conjugate prior-to-posterior calculation. While a non-informative prior is placed on the investigational treatment, the control prior is constructed via the meta-analytic-predictive approach. The design parameters including sample size and allocation ratio are then optimized, maximizing the probability of taking the right decision. The approach is illustrated with an example in lung cancer.
SMMR Other · 发表于 2017-12-28
Hua He, Hui Zhang, Peng Ye, Wan Tang
摘要
Excessive zeros are common in practice and may cause overdispersion and invalidate inference when fitting Poisson regression models. There is a large body of literature on zero-inflated Poisson models. However, methods for testing whether there are excessive zeros are less well developed. The Vuong test comparing a Poisson and a zero-inflated Poisson model is commonly applied in practice. However, the type I error of the test often deviates seriously from the nominal level, rendering serious doubts on the validity of the test in such applications. In this paper, we develop a new approach for testing inflated zeros under the Poisson model. Unlike the Vuong test for inflated zeros, our method does not require a zero-inflated Poisson model to perform the test. Simulation studies show that when compared with the Vuong test our approach not only better at controlling type I error rate, but also yield more power.
SiM Survival Analysis Clinical Trials · 发表于 2017-12-27
Qing Yang, Wing K. Fung, Gang Li
摘要
This article considers sample size determination for jointly testing a cause‐specific hazard and the all‐cause hazard for competing risks data. The cause‐specific hazard and the all‐cause hazard jointly characterize important study end points such as the disease‐specific survival and overall survival, which are commonly used as coprimary end points in clinical trials. Specifically, we derive sample size calculation methods for 2‐group comparisons based on an asymptotic chi‐square joint test and a maximum joint test of the aforementioned quantities, taking into account censoring due to lost to follow‐up as well as staggered entry and administrative censoring. We illustrate the application of the proposed methods using the Die Deutsche Diabetes Dialyse Studies clinical trial. An R package “powerCompRisk” has been developed and made available at the CRAN R library.
Biometrika Econometrics & Economics · 发表于 2017-12-26
L W Miratrix, S Wager, J R Zubizarreta
摘要
Estimating a population mean from a sample obtained with unknown selection probabilities is important in the biomedical and social sciences. Using a ratio estimator, Aronow & Lee (2013) proposed a method for partial identification of the mean by allowing the unknown selection probabilities to vary arbitrarily between two fixed values. In this paper, we show how to use auxiliary shape constraints on the population outcome distribution, such as symmetry or log-concavity, to obtain tighter bounds on the population mean. We use this method to estimate the performance of Aymara students, an ethnic minority in the north of Chile, in a national educational standardized test. We implement this method in the R package scbounds. *(abstract via OpenAlex)*
SiM Nonparametric & Semiparametric Bayesian Methods · 发表于 2017-12-26
Feng Guo, Inyoung Kim, Sheila G. Klauer
摘要
Driver behavior is a major contributing factor for traffic crashes, a leading cause of death and injury in the United States. The naturalistic driving study (NDS) revolutionizes driver behavior research by using sophisticated nonintrusive in‐vehicle instrumentation to continuously record driving data. This paper uses a case‐crossover approach to evaluate driver‐behavior risk. To properly model the unbalanced and clustered binary outcomes, we propose a semiparametric hierarchical mixed‐effect model to accommodate both among‐strata and within‐stratum variations. This approach overcomes several major limitations of the standard models, eg, constant stratum effect assumption for conditional logistic model. We develop 2 methods to calculate the marginal conditional probability. We show the consistency of parameter estimation and asymptotic equivalence of alternative estimation methods. A simulation study indicates that the proposed model is more efficient and robust than alternatives. We applied the model to the 100‐Car NDS data, a large‐scale NDS with 102 participants and 12‐month data collection. The results indicate that cell phone dialing increased the crash/near‐crash risk by 2.37 times (odds ratio: 2.37, 95% CI, 1.30‐4.30) and drowsiness increased the risk 33.56 times (odds ratio: 33.56, 95% CI, 21.82‐52.19). This paper provides new insight into driver behavior risk and novel analysis strategies for NDS studies.
SMMR Causal Inference · 发表于 2017-12-26
Rob Kessels, Reagan Mozer, Jos Bloemers
摘要
The placebo serves as an indispensable control in many randomized trials. When analyzing the benefit of a new treatment, researchers are often confronted with large placebo effects that diminish the treatment effect. Various alternative methods have been proposed for analyzing placebo and treatment effects in studies where large placebo effects are expected or have already occurred. This paper presents an overview of methodological work that has been proposed for assessing and/or controlling for placebo effects in randomized trials. Throughout this paper, two main approaches are discussed. The first approach considers designs that represent alternatives to the classical placebo-controlled randomized trial design. Separately, the second approach considers adopting new methods for the statistical analysis of placebo and treatment effects to be implemented after the data have been collected using a classical randomized trial design.
SMMR Bayesian Methods Latent Variables & Mixtures Nonparametric & Semiparametric · 发表于 2017-12-26
Kai Kang, Jingheng Cai, Xinyuan Song, Hongtu Zhu
摘要
Alzheimer’s disease is a firmly incurable and progressive disease. The pathology of Alzheimer’s disease usually evolves from cognitive normal, to mild cognitive impairment, to Alzheimer’s disease. The aim of this paper is to develop a Bayesian hidden Markov model to characterize disease pathology, identify hidden states corresponding to the diagnosed stages of cognitive decline, and examine the dynamic changes of potential risk factors associated with the cognitive normal–mild cognitive impairment–Alzheimer’s disease transition. The hidden Markov model framework consists of two major components. The first one is a state-dependent semiparametric regression for delineating the complex associations between clinical outcomes of interest and a set of prognostic biomarkers across neurodegenerative states. The second one is a parametric transition model, while accounting for potential covariate effects on the cross-state transition. The inter-individual and inter-process differences are taken into account via correlated random effects in both components. Based on the Alzheimer’s Disease Neuroimaging Initiative data set, we are able to identify four states of Alzheimer’s disease pathology, corresponding to common diagnosed cognitive decline stages, including cognitive normal, early mild cognitive impairment, late mild cognitive impairment, and Alzheimer’s disease and examine the effects of hippocampus, age, gender, and APOE-[Formula: see text] on degeneration of cognitive function across the four cognitive states.
SMMR Causal Inference Survival Analysis · 发表于 2017-12-26
Chuen Seng Tan, Nathalie C Støer, Ying Chen, Marielle Andersson, Yilin Ning, Hwee-Lin Wee, Eric Yin Hao Khoo, E-Shyong Tai, Shih Ling Kao, Marie Reilly
摘要
The control of confounding is an area of extensive epidemiological research, especially in the field of causal inference for observational studies. Matched cohort and case-control study designs are commonly implemented to control for confounding effects without specifying the functional form of the relationship between the outcome and confounders. This paper extends the commonly used regression models in matched designs for binary and survival outcomes (i.e. conditional logistic and stratified Cox proportional hazards) to studies of continuous outcomes through a novel interpretation and application of logit-based regression models from the econometrics and marketing research literature. We compare the performance of the maximum likelihood estimators using simulated data and propose a heuristic argument for obtaining the residuals for model diagnostics. We illustrate our proposed approach with two real data applications. Our simulation studies demonstrate that our stratification approach is robust to model misspecification and that the distribution of the estimated residuals provides a useful diagnostic when the strata are of moderate size. In our applications to real data, we demonstrate that parity and menopausal status are associated with percent mammographic density, and that the mean level and variability of inpatient blood glucose readings vary between medical and surgical wards within a national tertiary hospital. Our work highlights how the same class of regression models, available in most statistical software, can be used to adjust for confounding in the study of binary, time-to-event and continuous outcomes.
SiM Other · 发表于 2017-12-26
Erin E. Gabriel, Martha Nason, Michael P. Fay, Dean A. Follmann
摘要
Testing the equality of 2 proportions for a control group versus a treatment group is a well‐researched statistical problem. In some settings, there may be strong historical data that allow one to reliably expect that the control proportion is one, or nearly so. While one‐sample tests or comparisons to historical controls could be used, neither can rigorously control the type I error rate in the event the true control rate changes. In this work, we propose an unconditional exact test that exploits the historical information while controlling the type I error rate. We sequentially construct a rejection region by first maximizing the rejection region in the space where all controls have an event, subject to the constraint that our type I error rate does not exceedαfor any true event rate; then with any remainingαwe maximize the additional rejection region in the space where one control avoids the event, and so on. When the true control event rate is one, our test is the most powerful nonrandomized test for all points in the alternative space. When the true control event rate is nearly one, we demonstrate that our test has equal or higher mean power, averaging over the alternative space, than a variety of well‐known tests. For the comparison of 4 controls and 4 treated subjects, our proposed test has higher power than all comparator tests. We demonstrate the properties of our proposed test by simulation and use our method to design a malaria vaccine trial.
Biometrika High-Dimensional · 发表于 2017-12-25
Marco Avella-Medina, Elvezio Ronchetti
摘要
Generalized linear models are popular for modelling a large variety of data. We consider variable selection through penalized methods by focusing on resistance issues in the presence of outlying data and other deviations from assumptions. We highlight the weaknesses of widely-used penalized M-estimators, propose a robust penalized quasilikelihood estimator, and show that it enjoys oracle properties in high dimensions and is stable in a neighbourhood of the model. We illustrate its finite-sample performance on simulated and real data. *(abstract via OpenAlex)*
SMMR Diagnostics & Prediction Bayesian Methods Clinical Trials · 发表于 2017-12-22
Brian J Smith, Reinhard R Beichel
摘要
Quantitative biomarkers derived from medical images are being used increasingly to help diagnose disease, guide treatment, and predict clinical outcomes. Measurement of quantitative imaging biomarkers is subject to bias and variability from multiple sources, including the scanner technologies that produce images, the approaches for identifying regions of interest in images, and the algorithms that calculate biomarkers from regions. Moreover, these sources may differ within and between the quantification methods employed by institutions, thus making it difficult to develop and implement multi-institutional standards. We present a Bayesian framework for assessing bias and variability in imaging biomarkers derived from different quantification methods, comparing agreement to a reference standard, studying prognostic performance, and estimating sample size for future clinical studies. The statistical methods are illustrated with data obtained from a positron emission tomography challenge conducted by members of the NCI's Quantitative Imaging Network program, in which tumor volumes were measured manually and with seven different semi-automated segmentation algorithms. Estimates and comparisons of bias and variability in the resulting measurements are provided along with an R software package for the technical performance analysis and an online web application for sample size and power analysis.
Biometrics Survival Analysis · 发表于 2017-12-21
Shih-Wei Chen, Chin-Tsang Chiang
摘要
Summary: This article mainly focuses on analyzing covariate data from incident and prevalent cohort studies and a prevalent sample with only baseline covariates of interest and truncation times. Our major task in both research streams is to identify the effects of covariates on a failure time through very general single-index survival regression models without observing survival outcomes. With a strict increase of the survival function in the linear predictor, the ratio of incident and prevalent covariate densities is shown to be a non-degenerate and monotonic function of the linear predictor under covariate-independent truncation. Without such a structural assumption, the conditional density of a truncation time in a prevalent cohort is ensured to be a non-degenerate function of the linear predictor. In light of these features, some innovative approaches, which are based on the maximum rank correlation estimation or the pseudo least integrated squares estimation, are developed to estimate the coefficients of covariates up to a scale factor. Existing theoretical results are further used to establish the -consistency and asymptotic normality of the proposed estimators. Moreover, extensive simulations are conducted to assess and compare the finite-sample performance of various estimators. To illustrate the methodological ideas, we also analyze data from the Worcester Heart Attack Study and the National Comorbidity Survey Replication.
SiM Survival Analysis Diagnostics & Prediction · 发表于 2017-12-20
Catherine Lee, Rebecca A. Betensky, for the Alzheimer's Disease Neuroimaging Initiative
摘要
Relating time‐varying biomarkers of Alzheimer's disease to time‐to‐event using a Cox model is complicated by the fact that Alzheimer's disease biomarkers are sparsely collected, typically only at study entry; this is problematic since Cox regression with time‐varying covariates requires observation of the covariate process at all failure times. The analysis might be simplified by using study entry as the time origin and treating the time‐varying covariate measured at study entry as a fixed baseline covariate. In this paper, we first derive conditions under which using an incorrect time origin of study entry results in consistent estimation of regression parameters when the time‐varying covariate is continuous and fully observed. We then derive conditions under which treating the time‐varying covariate as fixed at study entry results in consistent estimation. We provide methods for estimating the regression parameter when a functional form can be assumed for the time‐varying biomarker, which is measured only at study entry. We demonstrate our analytical results in a simulation study and apply our methods to data from the Rush Religious Orders Study and Memory and Aging Project and data from the Alzheimer's Disease Neuroimaging Initiative.
SMMR Other · 发表于 2017-12-20
Rami Yaari, Itai Dattner, Amit Huppert
摘要
Age-dependent dynamics is an important characteristic of many infectious diseases. Age-group epidemic models describe the infection dynamics in different age-groups by allowing to set distinct parameter values for each. However, such models are highly nonlinear and may have a large number of unknown parameters. Thus, parameter estimation of age-group models, while becoming a fundamental issue for both the scientific study and policy making in infectious diseases, is not a trivial task in practice. In this paper, we examine the estimation of the so-called next-generation matrix using incidence data of a single entire outbreak, and extend the approach to deal with recurring outbreaks. Unlike previous studies, we do not assume any constraints regarding the structure of the matrix. A novel two-stage approach is developed, which allows for efficient parameter estimation from both statistical and computational perspectives. Simulation studies corroborate the ability to estimate accurately the parameters of the model for several realistic scenarios. The model and estimation method are applied to real data of influenza-like-illness in Israel. The parameter estimates of the key relevant epidemiological parameters and the recovered structure of the estimated next-generation matrix are in line with results obtained in previous studies.
SiM Other · 发表于 2017-12-20
Georgios I. Papayiannis, Emmanuel A. Giakoumakis, Efstathios D. Manios, Spyros D. Moulopoulos, Kimon S. Stamatelopoulos, Savvas T. Toumanidis, Nikolaos A. Zakopoulos, Athanasios N. Yannacopoulos
摘要
In this work, a functional supervised learning scheme is proposed for the classification of subjects into normotensive and hypertensive groups, using solely the 24‐hour blood pressure data, relying on the concepts of Fréchet mean and Fréchet variance for appropriate deformable functional models for the blood pressure data. The schemes are trained on real clinical data, and their performance was assessed and found to be very satisfactory.
SiM Survival Analysis Survey & Sampling Clinical Trials · 发表于 2017-12-18
Yan Li, Tao Xiao, Dandan Liao, Mei‐Ling Ting Lee
摘要
The Cox proportional hazards (PH) model is a common statistical technique used for analyzing time‐to‐event data. The assumption of PH, however, is not always appropriate in real applications. In cases where the assumption is not tenable, threshold regression (TR) and other survival methods, which do not require the PH assumption, are available and widely used. These alternative methods generally assume that the study data constitute simple random samples. In particular, TR has not been studied in the setting of complex surveys that involve (1) differential selection probabilities of study subjects and (2) intracluster correlations induced by multistage cluster sampling. In this paper, we extend TR procedures to account for complex sampling designs. The pseudo‐maximum likelihood estimation technique is applied to estimate the TR model parameters. Computationally efficient Taylor linearization variance estimators that consider both the intracluster correlation and the differential selection probabilities are developed. The proposed methods are evaluated by using simulation experiments with various complex designs and illustrated empirically by using mortality‐linked Third National Health and Nutrition Examination Survey Phase II genetic data.
SMMR Testing & Uncertainty Meta-Analysis & Data Integration · 发表于 2017-12-18
Mohammed S Al-Rawi, Adelaide Freitas, João V Duarte, Joao P Cunha, Miguel Castelo-Branco
摘要
A fundamental question that often occurs in statistical tests is the normality of distributions. Countless distributions exist in science and life, but one distribution that is obtained via permutations, usually referred to as permutation distribution, is interesting. Although a permutation distribution should behave in accord with the central limit theorem, if both the independence condition and the identical distribution condition are fulfilled, no studies have corroborated this concurrence in functional magnetic resonance imaging data. In this work, we used Anderson–Darling test to evaluate the accordance level of permutation distributions of classification accuracies to normality expected under central limit theorem. A simulation study has been carried out using functional magnetic resonance imaging data collected, while human subjects responded to visual stimulation paradigms. Two scrambling schemes are evaluated: the first based on permuting both the training and the testing sets and the second on permuting only the testing set. The results showed that, while a normal distribution does not adequately fit to permutation distributions most of the times, it tends to be quite well acceptable when mean classification accuracies averaged over a set of different classifiers is considered. The results also showed that permutation distributions can be probabilistically affected by performing motion correction to functional magnetic resonance imaging data, and thus may weaken the approximation of permutation distributions to a normal law. Such findings, however, have no relation to univariate/univoxel analysis of functional magnetic resonance imaging data. Overall, the results revealed a strong dependence across the folds of cross-validation and across functional magnetic resonance imaging runs and that may hinder the reliability of using cross-validation. The obtained p-values and the drawn confidence level intervals exhibited beyond doubt that different permutation schemes may beget different permutation distributions as well as different levels of accord with central limit theorem. We also found that different permutation schemes can lead to different permutation distributions and that may lead to different assessment of the statistical significance of classification accuracy.
SMMR Clinical Trials · 发表于 2017-12-18
Thomas Ondra, Sebastian Jobjörnsson, Robert A Beckman, Carl-Fredrik Burman, Franz König, Nigel Stallard, Martin Posch
摘要
Based on a Bayesian decision theoretic approach, we optimize frequentist single- and adaptive two-stage trial designs for the development of targeted therapies, where in addition to an overall population, a pre-defined subgroup is investigated. In such settings, the losses and gains of decisions can be quantified by utility functions that account for the preferences of different stakeholders. In particular, we optimize expected utilities from the perspectives both of a commercial sponsor, maximizing the net present value, and also of the society, maximizing cost-adjusted expected health benefits of a new treatment for a specific population. We consider single-stage and adaptive two-stage designs with partial enrichment, where the proportion of patients recruited from the subgroup is a design parameter. For the adaptive designs, we use a dynamic programming approach to derive optimal adaptation rules. The proposed designs are compared to trials which are non-enriched (i.e. the proportion of patients in the subgroup corresponds to the prevalence in the underlying population). We show that partial enrichment designs can substantially improve the expected utilities. Furthermore, adaptive partial enrichment designs are more robust than single-stage designs and retain high expected utilities even if the expected utilities are evaluated under a different prior than the one used in the optimization. In addition, we find that trials optimized for the sponsor utility function have smaller sample sizes compared to trials optimized under the societal view and may include the overall population (with patients from the complement of the subgroup) even if there is substantial evidence that the therapy is only effective in the subgroup.
SiM Longitudinal Data · 发表于 2017-12-18
Maria Sudell, Catrin Tudur Smith, François Gueyffier, Ruwanthi Kolamunnage‐Dona
摘要
Background: Joint modelling of longitudinal and time‐to‐event data is often preferred over separate longitudinal or time‐to‐event analyses as it can account for study dropout, error in longitudinally measured covariates, and correlation between longitudinal and time‐to‐event outcomes. The joint modelling literature focuses mainly on the analysis of single studies with no methods currently available for the meta‐analysis of joint model estimates from multiple studies. Methods: We propose a 2‐stage method for meta‐analysis of joint model estimates. These methods are applied to the INDANA dataset to combine joint model estimates of systolic blood pressure with time to death, time to myocardial infarction, and time to stroke. Results are compared to meta‐analyses of separate longitudinal or time‐to‐event models. A simulation study is conducted to contrast separate versus joint analyses over a range of scenarios. Results: Using the real dataset, similar results were obtained by using the separate and joint analyses. However, the simulation study indicated a benefit of use of joint rather than separate methods in a meta‐analytic setting where association exists between the longitudinal and time‐to‐event outcomes. Conclusions: Where evidence of association between longitudinal and time‐to‐event outcomes exists, results from joint models over standalone analyses should be pooled in 2‐stage meta‐analyses.
SiM Longitudinal Data Latent Variables & Mixtures · 发表于 2017-12-18
Paul S. Albert
摘要
Naturalistic driving studies provide opportunities for investigating the effects of key driving exposures on risky driving performance and accidents. New technology provides a realistic assessment of risky driving through the intensive monitoring of kinematic behavior while driving. These studies with their complex data structures provide opportunities for statisticians to develop needed modeling techniques for statistical inference. This article discusses new statistical modeling procedures that were developed to specifically answer important analytical questions for naturalistic driving studies. However, these methodologies also have important applications for the analysis of intensively collected longitudinal data, an increasingly common data structure with the advent of wearable devises. To examine the sources of variation between‐ and within‐participants in risky driving behavior, we explore the use of generalized linear mixed models with autoregressive random processes to analyzing long sequences of kinematic count data from a group of teenagers that have measurements at each trip over a 1.5‐year observation period starting after receiving their license. These models provide a regression framework for examining the effects of driving conditions and exposures on risky driving behavior. Alternatively, generalized estimating equations approaches are explored for the situation where we have intensively collected count measurements on a moderate number of participants. In addition to proposing statistical modeling for kinematic events, we explore models for relating kinematic events with crash risk. Specifically, we propose both latent variable and hidden Markov models for relating these 2 processes and for developing dynamic predictors of crash risk from longitudinal kinematic event data. These different statistical modeling techniques are all used to analyze data from the Naturalistic Teenage Driving Study, a unique investigation into how teenagers drive after licensure.
SMMR Causal Inference · 发表于 2017-12-18
Edward H Kennedy, Shreya Kangovi, Nandita Mitra
摘要
In classical study designs, the aim is often to learn about the effects of a treatment or intervention on a single outcome; in many modern studies, however, data on multiple outcomes are collected and it is of interest to explore effects on multiple outcomes simultaneously. Such designs can be particularly useful in patient-centered research, where different outcomes might be more or less important to different patients. In this paper, we propose scaled effect measures (via potential outcomes) that translate effects on multiple outcomes to a common scale, using mean-variance and median-interquartile range based standardizations. We present efficient, nonparametric, doubly robust methods for estimating these scaled effects (and weighted average summary measures), and for testing the null hypothesis that treatment affects all outcomes equally. We also discuss methods for exploring how treatment effects depend on covariates (i.e., effect modification). In addition to describing efficiency theory for our estimands and the asymptotic behavior of our estimators, we illustrate the methods in a simulation study and a data analysis. Importantly, and in contrast to much of the literature concerning effects on multiple outcomes, our methods are nonparametric and can be used not only in randomized trials to yield increased efficiency, but also in observational studies with high-dimensional covariates to reduce confounding bias.
SiM Longitudinal Data · 发表于 2017-12-18
Antoine Barbieri, Myriam Tami, Xavier Bry, David Azria, Sophie Gourgou, Caroline Bascoul‐Mollevi, Christian Lavergne
摘要
Health‐related quality of life (HRQoL) data are measured via patient questionnaires, completed by the patients themselves at different time points. We focused on oncology data gathered through the use of European Organization for Research and Treatment of Cancer questionnaires, which decompose HRQoL into several functional dimensions, several symptomatic dimensions, and the global health status (GHS). We aimed to perform a global analysis of HRQoL and reduce the number of analyses required by using a two‐step approach. First, a structural equation model (SEM) was used for each time point; in these models, the GHS is explained by two latent variables. Each latent variable is a factor that summarizes, respectively, the functional dimensions and the symptomatic dimensions to the global measurement. This is achieved through the maximization of the likelihood of each SEM using the EM algorithm, which has the advantage of giving an estimation of the subject‐specific factors and the influence of additional explanatory variables. Then, to consider the longitudinal aspect, the GHS variable and the two factors were concatenated for each patient visit at which the questionnaire was completed. The GHS and the two factors estimated in the first step can then be explained by additional explanatory variables using a linear mixed model.
Biometrics Longitudinal Data · 发表于 2017-12-18
Neal O. Jeffries, James F. Troendle, Nancy L. Geller
摘要
Summary: In longitudinal studies comparing two treatments over a series of common follow-up measurements, there may be interest in determining if there is a treatment difference at any follow-up period when there may be a non-monotone treatment effect over time. To evaluate this question, Jeffries and Geller (2015) examined a number of clinical trial designs that allowed adaptive choice of the follow-up time exhibiting the greatest evidence of treatment difference in a group sequential testing setting with Gaussian data. The methods are applicable when a few measurements were taken at prespecified follow-up periods. Here, we test the intersection null hypothesis of no difference at any follow-up time versus the alternative that there is a difference for at least one follow-up time. Results of Jeffries and Geller (2015) are extended by considering a broader range of modeled data and the inclusion of covariates using generalized estimating equations. Testing procedures are developed to determine a set of follow-up times that exhibit a treatment difference that accounts for multiplicity in follow-up times and interim analyses.
SMMR Causal Inference Bayesian Methods Machine Learning · 发表于 2017-12-18
Brent R Logan, Rodney Sparapani, Robert E McCulloch, Purushottam W Laud
摘要
Individualized treatment rules can improve health outcomes by recognizing that patients may respond differently to treatment and assigning therapy with the most desirable predicted outcome for each individual. Flexible and efficient prediction models are desired as a basis for such individualized treatment rules to handle potentially complex interactions between patient factors and treatment. Modern Bayesian semiparametric and nonparametric regression models provide an attractive avenue in this regard as these allow natural posterior uncertainty quantification of patient specific treatment decisions as well as the population wide value of the prediction-based individualized treatment rule. In addition, via the use of such models, inference is also available for the value of the optimal individualized treatment rules. We propose such an approach and implement it using Bayesian Additive Regression Trees as this model has been shown to perform well in fitting nonparametric regression functions to continuous and binary responses, even with many covariates. It is also computationally efficient for use in practice. With Bayesian Additive Regression Trees, we investigate a treatment strategy which utilizes individualized predictions of patient outcomes from Bayesian Additive Regression Trees models. Posterior distributions of patient outcomes under each treatment are used to assign the treatment that maximizes the expected posterior utility. We also describe how to approximate such a treatment policy with a clinically interpretable individualized treatment rule, and quantify its expected outcome. The proposed method performs very well in extensive simulation studies in comparison with several existing methods. We illustrate the usage of the proposed method to identify an individualized choice of conditioning regimen for patients undergoing hematopoietic cell transplantation and quantify the value of this method of choice in relation to the optimal individualized treatment rule as well as non-individualized treatment strategies.
SiM Testing & Uncertainty Networks & Graphs · 发表于 2017-12-18
Hisashi Noma, Kengo Nagashima, Kazushi Maruo, Masahiko Gosho, Toshi A. Furukawa
摘要
In network meta‐analyses that synthesize direct and indirect comparison evidence concerning multiple treatments, multivariate random effects models have been routinely used for addressing between‐studies heterogeneities. Although their standard inference methods depend on large sample approximations (eg, restricted maximum likelihood estimation) for the number of trials synthesized, the numbers of trials are often moderate or small. In these situations, standard estimators cannot be expected to behave in accordance with asymptotic theory; in particular, confidence intervals cannot be assumed to exhibit their nominal coverage probabilities (also, the type I error probabilities of the corresponding tests cannot be retained). The invalidity issue may seriously influence the overall conclusions of network meta‐analyses. In this article, we develop several improved inference methods for network meta‐analyses to resolve these problems. We first introduce 2 efficient likelihood‐based inference methods, the likelihood ratio test–based and efficient score test–based methods, in a general framework of network meta‐analysis. Then, to improve the small‐sample inferences, we developed improved higher‐order asymptotic methods using Bartlett‐type corrections and bootstrap adjustment methods. The proposed methods adopt Monte Carlo approaches using parametric bootstraps to effectively circumvent complicated analytical calculations of case‐by‐case analyses and to permit flexible application to various statistical models network meta‐analyses. These methods can also be straightforwardly applied to multivariate meta‐regression analyses and to tests for the evaluation of inconsistency. In numerical evaluations via simulations, the proposed methods generally performed well compared with the ordinary restricted maximum likelihood–based inference method. Applications to 2 network meta‐analysis datasets are provided.
Biometrika Bayesian Methods Survey & Sampling Longitudinal Data · 发表于 2017-12-18
Z Wang, J K Kim, S Yang
摘要
Statistical inference with complex survey data is challenging because the sampling design can be informative, and ignoring it can produce misleading results. Current methods of Bayesian inference under complex sampling assume that the sampling design is noninformative for the specified model. In this paper, we propose a Bayesian approach which uses the sampling distribution of a summary statistic to derive the posterior distribution of the parameters of interest. Asymptotic properties of the method are investigated. It is directly applicable to combining information from two independent surveys and to calibration estimation in survey sampling. A simulation study confirms that it can provide valid estimation under informative sampling. We apply it to a measurement error problem using data from the Korean Longitudinal Study of Aging. *(abstract via OpenAlex)*
SiM Diagnostics & Prediction · 发表于 2017-12-18
Glen P. Martin, Mamas A. Mamas, Niels Peek, Iain Buchan, Matthew Sperrin
摘要
There is growing interest in developing clinical prediction models (CPMs) to aid local healthcare decision‐making. Frequently, these CPMs are developed in isolation across different populations, with repetitive de novo derivation a common modelling strategy. However, this fails to utilise all available information and does not respond to changes in health processes through time and space. Alternatively, model updating techniques have previously been proposed that adjust an existing CPM to suit the new population, but these techniques are restricted to a single model. Therefore, we aimed to develop a generalised method for updating and aggregating multiple CPMs. The proposed “hybrid method” re‐calibrates multiple CPMs using stacked regression while concurrently revising specific covariates using individual participant data (IPD) under a penalised likelihood. The performance of the hybrid method was compared with existing methods in a clinical example of mortality risk prediction after transcatheter aortic valve implantation, and in 2 simulation studies. The simulation studies explored the effect of sample size and between‐population‐heterogeneity on the method, with each representing a situation of having multiple distinct CPMs and 1 set of IPD. When the sample size of the IPD was small, stacked regression and the hybrid method had comparable but highest performance across modelling methods. Conversely, in large IPD samples, development of a new model and the hybrid method gave the highest performance. Hence, the proposed strategy can inform the choice between utilising existing CPMs or developing a model de novo, thereby incorporating IPD, existing research, and prior (clinical) knowledge into the modelling strategy.
SiM Causal Inference Bayesian Methods Nonparametric & Semiparametric · 发表于 2017-12-18
Chanmin Kim, Michael Daniels, Yisheng Li, Kathrin Milbury, Lorenzo Cohen
摘要
In assessing causal mediation effects in randomized studies, a challenge is that the direct and indirect effects can vary across participants due to different measured and unmeasured characteristics. In that case, the population effect estimated from standard approaches implicitly averages over and does not estimate the heterogeneous direct and indirect effects. We propose a Bayesian semiparametric method to estimate heterogeneous direct and indirect effects via clusters, where the clusters are formed by both individual covariate profiles and individual effects due to unmeasured characteristics. These cluster‐specific direct and indirect effects can be estimated through a set of regression models where specific coefficients are clustered by a stick‐breaking prior. To let clustering be appropriately informed by individual direct and indirect effects, we specify a data‐dependent prior. We conduct simulation studies to assess performance of the proposed method compared to other methods. We use this approach to estimate heterogeneous causal direct and indirect effects of an expressive writing intervention for patients with renal cell carcinoma.
SMMR Other · 发表于 2017-12-15
Pablo Martínez-Camblor, Juan C Pardo-Fernández
摘要
Diagnostic procedures are based on establishing certain conditions and then checking if those conditions are satisfied by a given individual. When the diagnostic procedure is based on a continuous marker, this is equivalent to fix a region or classification subset and then check if the observed value of the marker belongs to that region. Receiver operating characteristic curve is a valuable and popular tool to study and compare the diagnostic ability of a given marker. Besides, the area under the receiver operating characteristic curve is frequently used as an index of the global discrimination ability. This paper revises and widens the scope of the receiver operating characteristic curve definition by setting the classification subsets in which the final decision is based in the spotlight of the analysis. We revise the definition of the receiver operating characteristic curve in terms of particular classes of classification subsets and then focus on a receiver operating characteristic curve generalization for situations in which both low and high values of the marker are associated with more probability of having the studied characteristic. Parametric and non-parametric estimators of the receiver operating characteristic curve generalization are investigated. Monte Carlo studies and real data examples illustrate their practical performance.
SMMR Bayesian Methods High-Dimensional Missing Data & Measurement Error · 发表于 2017-12-15
Rianne Jacobs, Emmanuel Lesaffre, Peter FM Teunis, Michael Höhle, Jan van de Kassteele
摘要
Early identification of contaminated food products is crucial in reducing health burdens of food-borne disease outbreaks. Analytic case-control studies are primarily used in this identification stage by comparing exposures in cases and controls using logistic regression. Standard epidemiological analysis practice is not formally defined and the combination of currently applied methods is subject to issues such as response misclassification, missing values, multiple testing problems and small sample estimation problems resulting in biased and possibly misleading results. In this paper, we develop a formal Bayesian variable selection method to account for misclassified responses and missing covariates, which are common complications in food-borne outbreak investigations. We illustrate the implementation and performance of our method on a Salmonella Thompson outbreak in the Netherlands in 2012. Our method is shown to perform better than the standard logistic regression approach with respect to earlier identification of contaminated food products. It also allows relatively easy implementation of otherwise complex methodological issues.
SMMR Causal Inference Missing Data & Measurement Error · 发表于 2017-12-15
Di Shu, Grace Y Yi
摘要
Inverse probability weighting estimation has been popularly used to consistently estimate the average treatment effect. Its validity, however, is challenged by the presence of error-prone variables. In this paper, we explore the inverse probability weighting estimation with mismeasured outcome variables. We study the impact of measurement error for both continuous and discrete outcome variables and reveal interesting consequences of the naive analysis which ignores measurement error. When a continuous outcome variable is mismeasured under an additive measurement error model, the naive analysis may still yield a consistent estimator; when the outcome is binary, we derive the asymptotic bias in a closed-form. Furthermore, we develop consistent estimation procedures for practical scenarios where either validation data or replicates are available. With validation data, we propose an efficient method for estimation of average treatment effect; the efficiency gain is substantial relative to usual methods of using validation data. To provide protection against model misspecification, we further propose a doubly robust estimator which is consistent even when either the treatment model or the outcome model is misspecified. Simulation studies are reported to assess the performance of the proposed methods. An application to a smoking cessation dataset is presented.
SMMR Bayesian Methods Nonparametric & Semiparametric · 发表于 2017-12-15
Vanda Inácio de Carvalho, Adam J Branscum
摘要
The three-class Youden index serves both as a measure of medical test accuracy and a criterion to choose the optimal pair of cutoff values for classifying subjects into three ordinal disease categories (e.g. no disease, mild disease, advanced disease). We present a Bayesian nonparametric approach for estimating the three-class Youden index and its corresponding optimal cutoff values based on Dirichlet process mixtures, which are robust models that can handle intricate features of distributions for complex data. Results from a simulation study are presented and an application to data from the Trail Making Test to assess cognitive impairment in Parkinson’s disease patients is detailed.
SiM Nonparametric & Semiparametric · 发表于 2017-12-15
Weihua Zhao, Heng Lian, Dipankar Bandyopadhyay
摘要
Proportion data with support lying in the interval [0,1] are a commonplace in various domains of medicine and public health. When these data are available as clusters, it is important to correctly incorporate the within‐cluster correlation to improve the estimation efficiency while conducting regression‐based risk evaluation. Furthermore, covariates may exhibit a nonlinear relationship with the (proportion) responses while quantifying disease status. As an alternative to various existing classical methods for modeling proportion data (such as augmented Beta regression) that uses maximum likelihood, or generalized estimating equations, we develop a partially linear additive model based on the quadratic inference function. Relying on quasi‐likelihood estimation techniques and polynomial spline approximation for unknown nonparametric functions, we obtain the estimators for both parametric part and nonparametric part of our model and study their large‐sample theoretical properties. We illustrate the advantages and usefulness of our proposition over other alternatives via extensive simulation studies, and application to a real dataset from a clinical periodontal study.
Biometrics Survival Analysis · 发表于 2017-12-14
Dean Follmann, Chiung-Yu Huang
摘要
Summary: Assessment of vaccine efficacy as a function of the similarity of the infecting pathogen to the vaccine is an important scientific goal. Characterization of pathogen strains for which vaccine efficacy is low can increase understanding of the vaccine's mechanism of action and offer targets for vaccine improvement. Traditional sieve analysis estimates differential vaccine efficacy using a single identifiable pathogen for each subject. The similarity between this single entity and the vaccine immunogen is quantified, for example, by exact match or number of mismatched amino acids. With new technology, we can now obtain the actual count of genetically distinct pathogens that infect an individual. Let F be the number of distinct features of a species of pathogen. We assume a log-linear model for the expected number of infecting pathogens with feature “f,” . The model can be used directly in studies with passive surveillance of infections where the count of each type of pathogen is recorded at the end of some interval, or active surveillance where the time of infection is known. For active surveillance, we additionally assume that a proportional intensity model applies to the time of potentially infectious exposures and derive product and weighted estimating equation (WEE) estimators for the regression parameters in the log-linear model. The WEE estimator explicitly allows for waning vaccine efficacy and time-varying distributions of pathogens. We give conditions where sieve parameters have a per-exposure interpretation under passive surveillance. We evaluate the methods by simulation and analyze a phase III trial of a malaria vaccine.